What is the worth of a nurse?
Really.
Im not talking metaphorically here, Im talking….put your money where your mouth is.
Sharn McNeill is an inspirational emergency department nurse from St George ED.
She was recently diagnosed with an aggressive form of motor neurone disease known as ALS (Amyotrophic Lateral Sclerosis). A disease disease which usually has a life expectancy of three to five years from diagnosis.
Sharn is attempting to raise money to undertake a cutting-edge stem cell treatment in the United States.
Cost: $500,000.
So. What is the worth of this nurse?
I always try to quickly get to a place of acceptance and gratitude. I feel blessed...
Source: impactEDnurse - August 25, 2013 Category: Nurses Authors: impactEDnurse Tags: ectopics Source Type: blogs
"WITHOUT THE BREAD OF LIFE, YOU ARE TOAST": As a Non-Biblical Expression, This Means What?
Discussion Blog)
Source: Bioethics Discussion Blog - August 1, 2013 Category: Health Medicine and Bioethics Commentators Source Type: blogs
Drug Research in China Falls Under a Cloud
Executives at the British drug maker GlaxoSmithKline were warned nearly two years ago about critical problems with the way the company conducted research at its drug development center in China, exposing it to potential financial risk and regulatory action, an internal audit found.The confidential document from November 2011, obtained by The New York Times, suggests that Glaxo’s problems may go beyond the sales practices that are currently at the center of a bribery and corruption scandal in China. They may extend to its Shanghai research and development center, which develops neurology drugs for Glaxo.The failings, some...
Source: PharmaGossip - July 23, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
Dan Wegner
From Harvard Gazette:
Daniel M. Wegner, a pioneering social psychologist who helped to reveal the mysteries of human experience through his work on thought suppression, conscious will, and mind perception, died July 5 as a result of amyotrophic lateral sclerosis (ALS). He was 65.
The John Lindsley Professor of Psychology in Memory of William James, Wegner redefined social psychology as the science of human experience. He was arguably most famous for his experiments on thought suppression, in which people were unable to keep from thinking of a white bear.
Wegner also broke ground in other areas of social psychology, includi...
Source: The Situationist - July 10, 2013 Category: Psychiatrists and Psychologists Authors: The Situationist Staff Tags: Illusions Life Social Psychology Source Type: blogs
Alzheimer's Drug Strikes Newly Identified Target, Halts Memory Loss
A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer's disease.
+Alzheimer's Reading Room
Developed in the laboratory of D. Martin Watterson, the molecules halted memory loss and fixed damaged communication among brain cells in a mouse model of Alzheimer's.
"This is the starting point for the development of a new class of drugs," said Watterson, lead author of a paper on the study and the John G. Searle Professor of Molecular Biology and Biochemistry at Northwestern University Feinberg School of Medicine. "It's poss...
Source: Alzheimer's Reading Room, The - July 6, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs
Spectroscopy now offers new insight into ALS
According to a study published in , Radiology 2013;267 851-857, Whole-Brain Analysis of Amyotrophic Lateral Sclerosis by Using Echo-Planar Spectroscopic Imaging: Significantly lower N-acetylaspartate (NAA)/creatinine and NAA/choline ratios in the precentral gyrus, midfrontal region, left caudate, occipital lobe, and other regions confirm that amyotrophic lateral sclerosis is a multisystem disorder of the entire brain and is not restricted to the motor cortex.
From Sumer's Radiology Site http://www.sumerdoc.blogspot.com -The Top Radiology Magazine. Teleradiology Providers at www.teleradproviders.com Mail us at sales@...
Source: Sumer's Radiology Site - May 28, 2013 Category: Radiologists Authors: Sumer Sethi Source Type: blogs
Raising Palliative Care Awareness Through Film Screeenings
(Ed. - Can you believe it another new author! Please welcome Paul Tatum @doctatum, a family medicine physician board certified in geriatrics and palliative care who practices medicine in at the University of Missouri in Columbia. Paul is no stranger to blogging and also posts at Geripal. Please welcome him to Pallimed! - Christian)
When I strike up conversation on the airplane and discussion turns to palliative medicine, the response tends to be either one of a blank stare and question about what is palliative medicine or a knowing smile and a ready story about how hospice and palliative medicine made a ...
Source: Pallimed: A Hospice and Palliative Medicine Blog - May 1, 2013 Category: Palliative Carer Workers Authors: Paul Tatum Source Type: blogs
Stem Cells and ALS
Most of us know amyotrophic lateral sclerosis (ALS) by its other name, Lou Gehrig’s disease. After a recent preliminary trial at Emory University yielded positive results, a phase II trial has been approved by the FDA. An article from Newswise described...(read more) (Source: ADVANCE Discourse: Lab)
Source: ADVANCE Discourse: Lab - April 17, 2013 Category: Pathologists Authors: Michael Jones Tags: Current Events Molecular Diagnostics Research Source Type: blogs
Trade Group Study: Hundreds of Rare Disease Drugs in Development
According to a new report released last month by the trade group Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical pipeline is innovative and robust, with a high percentage of potential first-in-class medicines (meaning a new treatment where nothing currently exists) targeting diseases with limited treatment options. In addition to identifying medicines in development for conditions and diseases such as septic shock, ovarian cancer, sickle cell disease, and Lou Gehrig’s disease (amyotrophic lateral sclerosis), which haven’t had any new product approvals in the last ten ye...
Source: Highlight HEALTH - February 21, 2013 Category: Medical Scientists Authors: Walter Jessen, Ph.D. Source Type: blogs
Is CTE Detectable in Living NFL Players?
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease seen most often in athletes with repeated concussions.1 The condition has drawn extensive media attention due to the number of cases reported among retired NFL players. The disease can only be diagnosed at autopsy, because the brain tissue has to be stained for characteristic protein abnormalities which cannot be visualized in a living human.Until now, that is, according to a new study by Gary Small and colleagues at UCLA (Small et al., 2013). Positron emission tomography (PET) and the molecular imaging probe FDDNP 2 were use to visuali...
Source: The Neurocritic - January 23, 2013 Category: Psychiatrists and Psychologists Authors: The Neurocritic Source Type: blogs
Biogen And ALS Patients Lose As A Key Trial Fails
In a blow to both a high-flying biotech and the relatively few patients with Lou Gehrig’s disease, a Phase III clinical trial being run by Biogen Idec showed that its dexpramipexole for treating amyotrophic lateral sclerosis failed to demonstrate any efficacy in improving either function or survival.
As a result, further study is being discontinued, a move that also disappointed investors, who sent Biogen (BIIB) shares down 6 percent in early trading. The failure comes almost exactly a year after Biogen ceo George Scangos told an investor conference the drug “is far from a long shot.” His declaration (bac...
Source: Pharmalot - January 3, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized ALS Biogen Idec Lou Gehrig New York Yankees Source Type: blogs
FDA to Genervon: Do the right thing ... or else.
The FDA said Genervon should supply more data if it wants an accelerated approval. The FDA took an unusual public stand Friday when it publicly asked Genervon Biopharmaceuticals to release all data from the California drugmaker's recently completed trial for an experimental drug for amyotrophic lateral sclerosis, a neurodegenerative disease also referred to as ALS and Lou Gehrig's disease. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - September 6, 2007 Category: Pharmaceuticals Source Type: blogs
